Condition
Optic Nerve Injuries
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
67%
2 of 3 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 2 (1)
Trial Status
Completed3
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06495580Not ApplicableNot Yet RecruitingPrimary
Optic Nerve Stimulation To Prevent Visual Deficits After Endoscopic Cranial Approaches
NCT01270126Not ApplicableCompleted
Trial of Alternating Current Stimulation in Optic Neuropathy
NCT02045212Phase 2Completed
Safety and Efficacy Study of RPh201 Treatment of Ischemic Optic Neuropathy (ION).
NCT01280877Not ApplicableCompleted
Paraorbital-Occipital Alternating Current Stimulation Therapy for Optic Neuropathy (MCT_optnerve)
Showing all 4 trials